Successful investigator-initiated trials start with a good question to get it up and running, and the right support to stay on track.
Join us for an empowering session highlighting what early career researchers and clinicians really need to know to equip themselves for success.
Dr Kortnye Smith and Dr Stephen Luen will discuss the most common issues faced when developing investigator-initiated trials and how to approach these issues, including how to bring a team together and how to find and secure funding. The webinar will also cover VCCC Alliance support services, including clinical trial protocol writing service and biostatistical support, powered by IQVIA.
Bring along your questions for our panel. This is a great opportunity to share your experiences with peers while unpacking challenges with expert support.
If you missed our first session, Current Challenges and Future Opportunities/Solutions for Trialists, watch the recording here.
Dr Kortnye Smith is a medical oncologist and researcher at Peter MacCallum Cancer Centre and Eastern Health. After completing her medical oncology training, she pursued a two-year fellowship at Peter MacCallum Cancer Centre and the Melbourne Genomic Health Alliance where she investigated genomic sequencing in cancer therapy. Kortnye works predominantly in lung cancer and melanoma as well as focusing on her passion to improve patient equity by coordinating the Oncology in the Home program in Melbourne.
Dr Stephen Luen is an early career Medical Oncologist and cancer researcher specialising in breast cancer, sarcoma, early drug development, and precision oncology. He completed his PhD investigating genomic and immune biomarkers in early stage breast cancers under the supervision of Professor Sherene Loi in 2021. He has subsequently developed an interest in generating novel clinical trials that apply precision oncology treatment approaches to treatment-resistant cancers. This work has led to the development of a number of investigator-initiated clinical trials in this space.
